{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:31:17Z","timestamp":1750825877167,"version":"3.32.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,21]]},"DOI":"10.7759\/cureus.76162","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T04:45:36Z","timestamp":1734842736000},"source":"Crossref","is-referenced-by-count":1,"title":["Assessment of Non-alcoholic Fatty Liver Disease and Level of Risk of Fibrosis in Diabetic and Non-diabetic Individuals"],"prefix":"10.7759","author":[{"given":"Miah","family":"Wahiduzzaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor-E-","family":"Ferdous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. M. Mozibul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. K. M. Shamsul","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Adib","family":"Siddiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Tanim","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qazi Ashrafur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al Istiak Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. H. M. Golam","family":"Kibria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al.. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023, 77:1797-835. 10.1097\/HEP.0000000000000323","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0365","article-title":"Global incidence and prevalence of nonalcoholic fatty liver disease","volume":"29","author":"Teng ML","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, et al.. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023, 29:S32-42. 10.3350\/cmh.2022.0365","journal-title":"Clin Mol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.171","article-title":"The global NAFLD epidemic","volume":"10","author":"Loomba R","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013, 10:686-90. 10.1038\/nrgastro.2013.171","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23567","article-title":"Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease","volume":"51","author":"Das K","year":"2010","unstructured":"Das K, Das K, Mukherjee PS, et al.. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010, 51:1593-602. 10.1002\/hep.23567","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3329\/jbcps.v35i4.34739","article-title":"Nonalcoholic fatty liver disease: a new frontier for hepatology in Bangladesh and a call for action to combat","volume":"35","author":"Alam S","year":"2017","unstructured":"Alam S, Hossain MM, Azam G, et al.. Nonalcoholic fatty liver disease: a new frontier for hepatology in Bangladesh and a call for action to combat. J Bangladesh College Phys Surg. 2017, 35:184-91. 10.3329\/jbcps.v35i4.34739","journal-title":"J Bangladesh College Phys Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12044","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh","volume":"2","author":"Alam S","year":"2018","unstructured":"Alam S, Fahim SM, Chowdhury MA, et al.. Prevalence and risk factors of non-alcoholic fatty liver disease in Bangladesh. JGH Open. 2018, 2:39-46. 10.1002\/jgh3.12044","journal-title":"JGH Open"},{"key":"ref7","article-title":"Nonalcoholic hepatic steatosis: a silent disease (Article in Spanish)","volume":"56","author":"Aguilera-M\u00e9ndez A","year":"2019","unstructured":"Aguilera-M\u00e9ndez A. Nonalcoholic hepatic steatosis: a silent disease (Article in Spanish). Rev Med Inst Mex Seguro Soc. 2019, 56:544-9.","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000535","article-title":"Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia","volume":"7","author":"Rahman MM","year":"2020","unstructured":"Rahman MM, Kibria MG, Begum H, et al.. Prevalence, risk factors and metabolic profile of the non-obese and obese non-alcoholic fatty liver disease in a rural community of South Asia. BMJ Open Gastroenterol. 2020, 7:000535. 10.1136\/bmjgast-2020-000535","journal-title":"BMJ Open Gastroenterol"},{"key":"ref9","article-title":"Nonalcoholic Fatty Liver","author":"Kudaravalli P","year":"2024","unstructured":"Kudaravalli P, John S. Nonalcoholic Fatty Liver. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.06.057","article-title":"Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"145","author":"Angulo P","year":"2013","unstructured":"Angulo P, Bugianesi E, Bjornsson ES, et al.. Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2013, 145:782-9.e4. 10.1053\/j.gastro.2013.06.057","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson S","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, et al.. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017, 112:740-51. 10.1038\/ajg.2016.453","journal-title":"Am J Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong VW","year":"2023","unstructured":"Wong VW, Ekstedt M, Wong GL, Hagstr\u00f6m H. Changing epidemiology, global trends and implications for outcomes of NAFLD. J Hepatol. 2023, 79:842-52. 10.1016\/j.jhep.2023.04.036","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: early detection should be focused","volume":"7","author":"Hossain MJ","year":"2024","unstructured":"Hossain MJ, Al-Mamun M, Islam MR. Diabetes mellitus, the fastest growing global public health concern: early detection should be focused. Health Sci Rep. 2024, 7:e2004. 10.1002\/hsr2.2004","journal-title":"Health Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4291\/wjgp.v7.i2.211","article-title":"Insulin resistance in development and progression of nonalcoholic fatty liver disease","volume":"7","author":"Alam S","year":"2016","unstructured":"Alam S, Mustafa G, Alam M, Ahmad N. Insulin resistance in development and progression of nonalcoholic fatty liver disease. World J Gastrointest Pathophysiol. 2016, 7:211-7. 10.4291\/wjgp.v7.i2.211","journal-title":"World J Gastrointest Pathophysiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055044","article-title":"Diabetes among adults in Bangladesh: changes in prevalence and risk factors between two cross-sectional surveys","volume":"12","author":"Chowdhury MA","year":"2022","unstructured":"Chowdhury MA, Islam M, Rahman J, Uddin MJ, Haque MR. Diabetes among adults in Bangladesh: changes in prevalence and risk factors between two cross-sectional surveys. BMJ Open. 2022, 12:e055044. 10.1136\/bmjopen-2021-055044","journal-title":"BMJ Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","author":"Angulo P","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346:1221-31. 10.1056\/NEJMra011775","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v14.i6.1226","article-title":"Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus","volume":"14","author":"Yamane R","year":"2022","unstructured":"Yamane R, Yoshioka K, Hayashi K, et al.. Prevalence of nonalcoholic fatty liver disease and its association with age in patients with type 2 diabetes mellitus. World J Hepatol. 2022, 14:1226-34. 10.4254\/wjh.v14.i6.1226","journal-title":"World J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_585_17","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"22","author":"Dharmalingam M","year":"2018","unstructured":"Dharmalingam M, Yamasandhi PG. Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab. 2018, 22:421-8. 10.4103\/ijem.IJEM_585_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12960","article-title":"Estimating the cost of illness of non-alcoholic fatty liver disease in Bangladesh","volume":"7","author":"Alam S","year":"2023","unstructured":"Alam S, Islam Alin MS, Begum F, Fahim SM, Tasnim Z, Alam MM. Estimating the cost of illness of non-alcoholic fatty liver disease in Bangladesh. JGH Open. 2023, 7:629-35. 10.1002\/jgh3.12960","journal-title":"JGH Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S002","article-title":"Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee. Diagnosis and classification of diabetes: standards of care in diabetes-2024. Diabet Care. 2024, 47:S20-42. 10.2337\/dc24-S002","journal-title":"Diabet Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.145.4.753","article-title":"Characteristic sonographic signs of hepatic fatty infiltration","volume":"145","author":"Quinn SF","year":"1985","unstructured":"Quinn SF, Gosink BB. Characteristic sonographic signs of hepatic fatty infiltration. AJR Am J Roentgenol. 1985, 145:753-5. 10.2214\/ajr.145.4.753","journal-title":"AJR Am J Roentgenol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah AG","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009, 7:1104-12. 10.1016\/j.cgh.2009.05.033","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher G","year":"2013","unstructured":"Targher G, Byrne CD. Clinical review: nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications. J Clin Endocrinol Metab. 2013, 98:483-95. 10.1210\/jc.2012-3093","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar D","year":"2007","unstructured":"Amarapurkar D, Kamani P, Patel N, et al.. Prevalence of non-alcoholic fatty liver disease: population based study. Ann Hepatol. 2007, 6:161-3. 10.1016\/S1665-2681(19)31922-2","journal-title":"Ann Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-014-0488-5","article-title":"Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh","volume":"33","author":"Alam S","year":"2014","unstructured":"Alam S, Gupta UD, Alam M, Kabir J, Chowdhury ZR, Alam AK. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh. Indian J Gastroenterol. 2014, 33:452-7. 10.1007\/s12664-014-0488-5","journal-title":"Indian J Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v5.i5.281","article-title":"Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh","volume":"5","author":"Alam S","year":"2013","unstructured":"Alam S, Noor-E-Alam SM, Chowdhury ZR, Alam M, Kabir J. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh. World J Hepatol. 2013, 5:281-7. 10.4254\/wjh.v5.i5.281","journal-title":"World J Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100220","article-title":"Prevalence and associated factors for non-alcoholic fatty liver\u00a0disease among adults in the South Asian Region: a meta-analysis","volume":"15","author":"Niriella MA","year":"2023","unstructured":"Niriella MA, Ediriweera DS, Withanage MY, Darshika S, De Silva ST, de Silva HD. Prevalence and associated factors for non-alcoholic fatty liver\u00a0disease among adults in the South Asian Region: a meta-analysis. Lancet Reg Health Southeast Asia. 2023, 15:100220. 10.1016\/j.lansea.2023.100220","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/dsi23-0013","article-title":"Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care","volume":"37","author":"Nogueira JP","year":"2024","unstructured":"Nogueira JP, Cusi K. Role of insulin resistance in the development of nonalcoholic fatty liver disease in people with type 2 diabetes: from bench to patient care. Diabetes Spectr. 2024, 37:20-8. 10.2337\/dsi23-0013","journal-title":"Diabetes Spectr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-03583-3","article-title":"A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight","volume":"11","author":"De Pergola G","year":"2021","unstructured":"De Pergola G, Castellana F, Zupo R, et al.. A family history of type 2 diabetes as a predictor of fatty liver disease in diabetes-free individuals with excessive body weight. Sci Rep. 2021, 11:24084. 10.1038\/s41598-021-03583-3","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye Q","year":"2020","unstructured":"Ye Q, Zou B, Yeo YH, et al.. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020, 5:739-52. 10.1016\/S2468-1253(20)30077-7","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/313341-assessment-of-non-alcoholic-fatty-liver-disease-and-level-of-risk-of-fibrosis-in-diabetic-and-non-diabetic-individuals","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T04:45:39Z","timestamp":1734842739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/313341-assessment-of-non-alcoholic-fatty-liver-disease-and-level-of-risk-of-fibrosis-in-diabetic-and-non-diabetic-individuals"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.76162","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}